Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
186 Leser
Artikel bewerten:
(1)

Veterinary Vaccines Market is expected to generate a revenue of USD 27.5 Billion By 2030, Globally, at 9.5% CAGR: Verified Market Research

Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, " Veterinary Vaccines Market Size and Forecast." This comprehensive report offers in-depth insights into the veterinary vaccines market, a rapidly evolving sector driven by technological innovations, rising pet ownership, and an increased emphasis on animal health and welfare across both companion and farm animal segments.

JERSEY CITY, N.J., Oct. 31, 2024 /PRNewswire/ -- The Global Veterinary Vaccines Market is projected to grow at a CAGR of 9.5% from 2024 to 2030, according to a new report published by Verified Market Research®. The report reveals that the market was valued at USD 19.10 Billion in 2023 and is expected to reach USD 27.5 Billion by the end of the forecast period.

Verified Market Research Logo

As the global veterinary vaccines market continues to witness robust growth, industry stakeholders need actionable insights to stay ahead. Our report provides an unparalleled view into the factors driving market expansion, such as rising zoonotic disease prevalence, heightened regulatory demands for vaccine quality and safety, and advances in biotechnology enabling more efficient and effective vaccine formulations. With data-driven forecasts, emerging trends, and competitive landscape analysis, this report empowers decision-makers with strategic knowledge essential for future-proofing their operations in this thriving sector.

This newly developed report will be an invaluable asset for stakeholders, including pharmaceutical companies, veterinary hospitals, livestock producers, research organizations, and government agencies.

Key features include:

Market Dynamics and Key Drivers: Detailed insights into factors propelling the market, from advancements in biotechnology to the rise in livestock-based food production and pet care.

Competitive Landscape: In-depth profiling of leading players, upcoming market entrants, and emerging innovators transforming veterinary medicine with cutting-edge vaccine solutions.

Regional and Segment Analysis: Comprehensive evaluation across regions, with forecasts to help businesses identify high-growth segments and strategically allocate resources.

Future Market Forecast: Projections based on primary and secondary research for informed, long-term strategic planning.

Stay ahead of the curve in the ever-evolving Diesel Generator Market. For more information or to request a sample copy of the report, please visit: https://www.verifiedmarketresearch.com/download-sample?rid=31751

Browse in-depth TOC on "Veterinary Vaccines Market"

202 - Pages
126 - Tables
37 - Figures

Report Scope:

REPORT ATTRIBUTES

DETAILS

STUDY PERIOD

2020-2030

BASE YEAR

2023

FORECAST PERIOD

2024-2030

HISTORICAL PERIOD

2020-2022

UNIT

Value (USD Billion)

KEY COMPANIES PROFILED

Zoetis Inc. (US), Merck & Co, Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health (US), Virbac (France).

SEGMENTS COVERED

By Type of Animal Type, By Vaccine Type, By Technology, By Geography

CUSTOMIZATION SCOPE

Free report customization (equivalent to up to 4 analyst working days) with purchase. Addition or alteration to country, regional & segment scope

Global Veterinary Vaccines Market Overview

Rising Zoonotic Diseases Demand for Proactive Solutions: With an increase in zoonotic disease transmission risks, the Veterinary Vaccines Market is experiencing substantial growth. Rising outbreaks in livestock and companion animals drive the need for preventive measures to safeguard both animal and human health. The demand for cost-effective vaccines has become crucial for livestock producers and pet owners, fueling market expansion. Key stakeholders can capitalize on this opportunity to innovate and deliver efficient, tailored vaccine solutions.

Technological Advancements in Vaccine Development: Cutting-edge biotechnology, such as DNA and recombinant vaccines, is transforming the Veterinary Vaccines Market by enabling more targeted and effective solutions. Advances reduce vaccine production times and improve efficacy, directly impacting disease control efforts across species. Industry leaders focused on research and development stand to benefit significantly from these innovations, allowing them to deliver enhanced immunity solutions and cater to the rising global demand for robust veterinary vaccines.

Growing Pet Ownership and Livestock Demand: The global increase in pet ownership and livestock production to meet food demands has amplified the Veterinary Vaccines Market. Pet owners seek reliable health protection for their animals, and livestock producers rely on vaccines to prevent costly disease outbreaks. This trend strengthens the demand for high-quality vaccines, encouraging businesses to scale production and introduce diverse vaccine options. Organizations investing in this area can enhance brand loyalty and capture a growing segment of the market.

To Purchase a Comprehensive Report Analysis: https://www.verifiedmarketresearch.com/select-licence?rid=31751

High R&D Costs and Regulatory Hurdles: Developing vaccines for diverse animal diseases requires significant R&D investment, contributing to high costs that may limit market growth. Additionally, the Veterinary Vaccines Market faces stringent regulatory frameworks to ensure vaccine safety, often delaying product approval and increasing time-to-market. Companies aiming to mitigate these constraints should focus on streamlining research processes and working closely with regulatory bodies to optimize development timelines and minimize expenses.

Limited Awareness in Emerging Markets: In emerging regions, where animal health infrastructure may be underdeveloped, there is often limited awareness of the benefits and availability of veterinary vaccines. This lack of knowledge affects vaccine adoption rates, constraining the Veterinary Vaccines Market's potential in key growth areas. Industry players can address this restraint by investing in educational campaigns and building partnerships with local veterinarians to raise awareness, thus boosting vaccine uptake and expanding market reach.

Storage and Distribution Challenges: Many veterinary vaccines require cold-chain storage and timely distribution to remain effective, which presents logistical challenges, particularly in remote and rural areas. Inconsistent storage can lead to product degradation, limiting market penetration. The Veterinary Vaccines Market can address these challenges by exploring alternative formulations and partnering with local distributors to improve cold-chain infrastructure, ensuring vaccine potency and enhancing accessibility across different regions.

Geographical Dominance

The Asia-Pacific region leads the Diesel Generator Market, propelled by swift industrialization, growing infrastructure, and rising power outages in nations like as China and India. The increasing demand for dependable backup power in the region is driving market expansion. Simultaneously, North America and Europe, possessing robust industrial foundations and an emphasis on energy efficiency, make substantial contributions. This regional demand enhances the market by offering varied chances across sectors.

Movers and Shakers: Key Players in Focus

In this competitive arena, industry giants like Zoetis Inc. (US), Merck & Co, Inc. (US), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health (US), Virbac (France). shape the Veterinary Vaccines Market's destiny.

Based on the research, Verified Market Research® has segmented the global Veterinary Vaccines Market into Vaccine Type, Technology, And Geography.

  • Veterinary Vaccines Market, by Vaccine Type
    • Livestock Vaccines
    • Companion Animal Vaccines
    • Aquaculture Vaccines
    • Other Animal Vaccines
  • Veterinary Vaccines Market, by Technology
    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • Other Vaccines
  • Veterinary Vaccines Market, by Geography
    • North America
      • U.S
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • U.K
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Rest of Asia Pacific
    • ROW
      • Middle East & Africa
      • Latin America

Browse Related Reports:

Veterinary Diagnostics Market By Technology (Haematology, Clinical Biochemistry, Immunodiagnostics, Molecular Diagnostics), By Animal Type (Companion Animals, Livestock Animals), By Geography, And Forecast

Veterinary Pain Management Market By Product Category (Devices, Drugs), By Application (Joint Pain, Postoperative Pain, Cancer), By Animal Type (Companion Animals, Livestock), By Distribution Channel (Hospitals & Clinics, Pharmacy), By Geography, And Forecast

Veterinary Autogenous Vaccines Market By Strain Type (Bacterial Strain, Virus Strain), By End User (Veterinary Clinics, Veterinary Hospitals), By Geography, And Forecast

Veterinary Infectious Disease Diagnostics Market By Product (Immunodiagnostics, ELISA), By Application (Lab, Hospital, Clinics, PoC) By Geography, And Forecast

10 Best Veterinary Dermatology Drugs Manufacturers for furry little companions

Visualize Veterinary Vaccines Market using Verified Market Intelligence -:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
US Toll Free: +1 (800)-782-1768
Email: sales@verifiedmarketresearch.com
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/2015407/VMR_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/veterinary-vaccines-market-is-expected-to-generate-a-revenue-of-usd-27-5-billion-by-2030--globally-at-9-5-cagr-verified-market-research-302292812.html

© 2024 PR Newswire
Nach Nvidia: 5 KI-Revolutionäre aus der zweiten Reihe!
Künstliche Intelligenz hat spätestens nach dem Raketenstart von Chat GPT das Leben aller verändert. Doch der Superzyklus steht nach Meinungen von Experten erst am Anfang. Während Aktien wie Nvidia von der ersten Aufwärtsentwicklung stark profitieren konnten, versprechen aussichtsreiche Player aus der

zweiten Reihe noch enormes Aufwärtspotenzial.

Im kostenlosen, exklusiven Spezialreport präsentieren wir ihnen 5 innovative KI-Unternehmen, die bahnbrechende Entwicklungen in diesem Sektor prägen könnten.

Warum sollten Sie dabei sein?
Trotz der jüngsten Erfolge steht die Entwicklung der künstlichen Intelligenz noch am Beginn eines neuen Superzyklus. Experten gehen davon aus, dass der Sektor bis 2032 global auf 1,3 Billionen US-Dollar explodieren wird, wobei ein großer Teil auf Hardware und Infrastruktur entfallen wird.

Nutzen Sie die Chance!
Fordern Sie sofort unseren brandneuen Spezialreport an und erfahren Sie, welche 5 KI-Aktien das größte Potenzial zur Vervielfachung besitzen. Dieser Report ist komplett kostenlos und zeigt Ihnen die aussichtsreichsten Investments im KI-Sektor.
Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.